JP2020127419A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020127419A5 JP2020127419A5 JP2020081545A JP2020081545A JP2020127419A5 JP 2020127419 A5 JP2020127419 A5 JP 2020127419A5 JP 2020081545 A JP2020081545 A JP 2020081545A JP 2020081545 A JP2020081545 A JP 2020081545A JP 2020127419 A5 JP2020127419 A5 JP 2020127419A5
- Authority
- JP
- Japan
- Prior art keywords
- analog
- seq
- shk
- analog according
- toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014903189 | 2014-08-15 | ||
| AU2014903189A AU2014903189A0 (en) | 2014-08-15 | Novel potassium channel blockers | |
| JP2017508102A JP6847828B2 (ja) | 2014-08-15 | 2015-08-14 | 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017508102A Division JP6847828B2 (ja) | 2014-08-15 | 2015-08-14 | 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020127419A JP2020127419A (ja) | 2020-08-27 |
| JP2020127419A5 true JP2020127419A5 (https=) | 2020-11-12 |
| JP6953579B2 JP6953579B2 (ja) | 2021-10-27 |
Family
ID=55303691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017508102A Active JP6847828B2 (ja) | 2014-08-15 | 2015-08-14 | 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 |
| JP2020081545A Active JP6953579B2 (ja) | 2014-08-15 | 2020-05-01 | 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017508102A Active JP6847828B2 (ja) | 2014-08-15 | 2015-08-14 | 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10246496B2 (https=) |
| EP (1) | EP3180365B1 (https=) |
| JP (2) | JP6847828B2 (https=) |
| AU (1) | AU2015303825B2 (https=) |
| WO (1) | WO2016023072A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3180365B1 (en) * | 2014-08-15 | 2021-08-18 | Monash University | Novel potassium channel blockers and use thereof in the treatment of autoimmune diseases |
| KR102533290B1 (ko) * | 2022-04-14 | 2023-05-16 | 한국해양과학기술원 | 전압개폐 칼륨이온채널 억제 활성능을 갖는 펩타이드 |
| KR102553070B1 (ko) * | 2022-06-16 | 2023-07-07 | 한국해양과학기술원 | 전압개폐 칼륨이온채널 억제 활성능을 갖는 작은상자해파리 기원 펩타이드 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005294124B2 (en) * | 2004-10-07 | 2012-02-23 | Bachem Biosciences, Inc. | Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels |
| PE20081140A1 (es) * | 2006-10-25 | 2008-09-22 | Amgen Inc | Agentes terapeuticos a base de peptidos derivados de toxinas |
| PT2158213E (pt) * | 2007-05-14 | 2012-03-27 | Univ Mexico Nacional Autonoma | Vm23 e vm24, dois péptidos de escorpião que bloqueiam canais de potássio de linfócitos t humanos (subtipo kv1.3) com elevada selectividade |
| CA2755336C (en) * | 2009-03-20 | 2015-07-14 | Amgen Inc. | Carrier immunoglobulins and uses thereof |
| SG195302A1 (en) * | 2011-06-06 | 2013-12-30 | Kineta One Llc | Shk-based pharmaceutical compositions and methods of manufacturing and using the same |
| LT2948559T (lt) * | 2013-01-25 | 2018-06-25 | Janssen Biotech, Inc. | Kv1.3 antagonistai ir jų panaudojimo būdai |
| EP3180365B1 (en) * | 2014-08-15 | 2021-08-18 | Monash University | Novel potassium channel blockers and use thereof in the treatment of autoimmune diseases |
-
2015
- 2015-08-14 EP EP15832619.9A patent/EP3180365B1/en active Active
- 2015-08-14 JP JP2017508102A patent/JP6847828B2/ja active Active
- 2015-08-14 WO PCT/AU2015/000487 patent/WO2016023072A1/en not_active Ceased
- 2015-08-14 AU AU2015303825A patent/AU2015303825B2/en active Active
- 2015-08-14 US US15/503,841 patent/US10246496B2/en active Active
-
2020
- 2020-05-01 JP JP2020081545A patent/JP6953579B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020127419A5 (https=) | ||
| JP2018138049A5 (https=) | ||
| JP2019527555A5 (https=) | ||
| SA522433360B1 (ar) | L-أَسْباراجيناز مُعدل | |
| JP2017018125A5 (https=) | ||
| JP2020518268A5 (https=) | ||
| JP2004267216A5 (https=) | ||
| JP2006516189A5 (https=) | ||
| JP2009527226A5 (https=) | ||
| Buckland et al. | Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses | |
| JP2013027391A5 (https=) | ||
| JP2024041747A5 (https=) | ||
| JP2020517260A5 (https=) | ||
| JP2019534884A5 (https=) | ||
| JP2018537089A5 (https=) | ||
| JP2014193147A5 (https=) | ||
| JP2008545393A5 (https=) | ||
| JP2017513849A5 (https=) | ||
| JP2011521661A5 (https=) | ||
| JP2002517193A5 (https=) | ||
| JP2024503091A5 (https=) | ||
| CA2202519A1 (en) | Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2004535161A5 (https=) | ||
| ATE501256T1 (de) | Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung |